Hazra T K, Hill J W, Izumi T, Mitra S
Sealy Center for Molecular Science, Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston, Texas 77555, USA.
Prog Nucleic Acid Res Mol Biol. 2001;68:193-205. doi: 10.1016/s0079-6603(01)68100-5.
8-Oxoguanine (8-oxoG) is a critical mutagenic lesion because of its propensity to mispair with A during DNA replication. All organisms, from bacteria to mammals, express at least two types of 8-oxoguanine-DNA glycosylase (OGG) for repair of 8-oxoG. The major enzyme class (OGG1), first identified in Escherichia coli as MutM (Fpg), and later in yeast and humans, excises 8-oxoG when paired with C, T, and G but rarely with A. In contrast, a distinct and less abundant OGG, OGG2, prefers 8-oxoG when paired with G and A as a substrate, and has been characterized in yeast and human cells. Recently, OGG2 activity was detected in E. coli which was subsequently identified to be Nei (Endo VIII). In view of the ubiquity of OGG2, we have proposed a model named "bipartite antimutagenic processing of 8-oxoguanine" and is an extension of the original "GO model." The GO model explains the presence of OGG1 (MutM) that excises 8-oxoG from nonreplicated DNA. If 8-oxoG mispairs with A during replication, MutY excises A and provides an opportunity for insertion of C opposite 8-oxoG during subsequent repair replication. Our model postulates that whereas OGG1 (MutM) is responsible for global repair of 8-oxoG in the nonreplicating genome, OGG2 (Nei) repairs 8-oxoG in nascent or transcriptionally active DNA. Interestingly, we observed that MutY and MutM reciprocally inhibited each other's catalytic activity but observed no mutual interference between Nei and MutY. This suggests that the recognition sites on the same substrate for Nei and MutY are nonoverlapping. Human OGG1 is distinct from other oxidized base-specific DNA glycosylases because of its extremely low turnover, weak AP lyase activity, and nonproductive affinity for the abasic (AP) site, its first reaction product. OGG1 is activated nearly 5-fold in the presence of AP-endonuclease (APE) as a result of its displacement by the latter. These results support the "handoff" mechanism of BER in which the enzymatic steps are coordinated as a result of displacement of the DNA glycosylase by APE, the next enzyme in the pathway. The physiological significance of multiple OGGs and their in vivo reaction mechanisms remain to be elucidated by further studies.
8-氧代鸟嘌呤(8-oxoG)是一种关键的诱变损伤,因为它在DNA复制过程中易于与腺嘌呤错配。从细菌到哺乳动物的所有生物都表达至少两种类型的8-氧代鸟嘌呤-DNA糖基化酶(OGG)来修复8-氧代鸟嘌呤。主要的酶类(OGG1),最初在大肠杆菌中被鉴定为MutM(Fpg),后来在酵母和人类中也被发现,当8-氧代鸟嘌呤与胞嘧啶、胸腺嘧啶和鸟嘌呤配对时可切除8-氧代鸟嘌呤,但很少与腺嘌呤配对时切除。相比之下,一种不同且含量较少的OGG,即OGG2,更倾向于将与鸟嘌呤和腺嘌呤配对的8-氧代鸟嘌呤作为底物进行修复,并且已经在酵母和人类细胞中得到了表征。最近,在大肠杆菌中检测到了OGG2活性,随后被鉴定为Nei(Endo VIII)。鉴于OGG2的普遍存在,我们提出了一个名为“8-氧代鸟嘌呤的二分抗诱变处理”的模型,它是原始“GO模型”的扩展。GO模型解释了OGG1(MutM)从未复制的DNA中切除8-氧代鸟嘌呤的存在。如果在复制过程中8-氧代鸟嘌呤与腺嘌呤错配,MutY会切除腺嘌呤,并在随后的修复复制过程中为在8-氧代鸟嘌呤对面插入胞嘧啶提供机会。我们的模型假设,虽然OGG1(MutM)负责非复制基因组中8-氧代鸟嘌呤的全局修复,但OGG2(Nei)修复新生或转录活跃DNA中的8-氧代鸟嘌呤。有趣的是,我们观察到MutY和MutM相互抑制彼此的催化活性,但未观察到Nei和MutY之间的相互干扰。这表明Nei和MutY在同一底物上的识别位点不重叠。人类OGG1与其他氧化碱基特异性DNA糖基化酶不同,因为其周转率极低、AP裂解酶活性弱以及对其第一个反应产物无碱基(AP)位点具有非生产性亲和力。由于被AP内切核酸酶(APE)取代,OGG1在其存在下被激活近5倍。这些结果支持碱基切除修复(BER)的“交接”机制,即由于DNA糖基化酶被途径中的下一个酶APE取代,酶促步骤得以协调。多种OGG的生理意义及其体内反应机制仍有待进一步研究阐明。